Screener
Cytek Biosciences, Inc. CTKB Q1 2026 earnings
Reported May 7, 2026 · After market close
Revenue$44.1MMiss by $98.3K
EPS-$0.12Miss by $0.04
Revenue estimate$44.2M
EPS estimate-$0.08
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$52.9M
EPS estimate-$0.07
Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Cytek Biosciences, Inc. report Q1 2026 earnings?
- Cytek Biosciences, Inc. (CTKB) reported Q1 2026 earnings on May 7, 2026 after market close.
- What were Cytek Biosciences, Inc.'s Q1 2026 revenue and EPS?
- Cytek Biosciences, Inc. reported revenue of $44.1M and eps of $-0.12 for Q1 2026.
- Did Cytek Biosciences, Inc. beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $44.2M by $98.3K. EPS missed the consensus estimate of $-0.08 by $0.04.
- How did Cytek Biosciences, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 6.5% from $41.5M a year earlier and eps declined 33.3% from $-0.09.
- Where can I find Cytek Biosciences, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-211948) and the 10-Q periodic report (0001628280-26-032293) directly on SEC EDGAR. The filing index links above go to sec.gov.
